Review Article
Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal Vaccines
Table 1
Status of development of plant-based vaccines.
| Pathogen | Antigen | Plant host | Expression system | Indication | Route of administration | Clinical trial status | Clinical trial ID | Refs |
| Enterotoxigenic E. coli | LT-B | Potato | Transgenic | Diarrhea | Edible | Early phase 1 | ▶ | [42] | Enterotoxigenic E. coli | LT-B | Maize | Transgenic | Diarrhea | Edible | Early phase 1 | ▶ | [43] | Norwalk virus | CP | Potato | Transgenic | Diarrhea | Edible | Early phase 1 | ▶ | [44] | Rabies virus | GP/NP (fusion) | Spinach | Viral vector (transient) | Rabies | Edible | Early phase 1 | ▶ | [45] | HBV | HBsAg | Lettuce | Transgenic | Hepatitis B | Edible | Early phase 1 | ▶ | [46] | HBV | HBsAg | Potato | Transgenic | Hepatitis B | Edible | Phase 1 | NCT01292421 | [47] | Vibrio cholerae | CTB | Rice | Transgenic | Cholera | Edible | Phase 1 | UMIN000009688 | [48–51] |
|
|
HBsAg: hepatitis B surface antigen; CP: capsid protein; GP: glycoprotein; NP: nucleoprotein; CTB: cholera toxin subunit B. ▶: restricted cohort study design.
|